McMillion Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$170K |
| 2 |
Genuine Parts
GPC
|
+$143K |
| 3 |
Kimberly-Clark
KMB
|
+$111K |
| 4 |
Johnson & Johnson
JNJ
|
+$100K |
| 5 |
Dow Inc
DOW
|
+$96.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPT
Medical Properties Trust
MPT
|
+$354K |
| 2 |
Costco
COST
|
+$174K |
| 3 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$136K |
| 4 |
Cheniere Energy
LNG
|
+$98K |
| 5 |
Apple
AAPL
|
+$95.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.27% |
| 2 | Industrials | 8.55% |
| 3 | Consumer Discretionary | 8.17% |
| 4 | Consumer Staples | 7.88% |
| 5 | Healthcare | 6.45% |
No holdings matched the selected filter criteria.
Similar funds
McMillion Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, McMillion Capital Management held 197 positions worth $112M, up 5.9% from $106M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
McMillion Capital Management's Q2 2023 filing shows 123 new, 49 reduced and 1 closed positions. Its largest new stake was General Mills: 1,985 shares worth $152K. The largest sale was Medical Properties Trust, an estimated $354K.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
- McMillion Capital Management's largest Q2 2023 buy was General Mills: 1,985 shares worth $152K.
- McMillion Capital Management's biggest Q2 2023 reduction was Costco, cutting an estimated $174K.
- McMillion Capital Management fully exited Medical Properties Trust in Q2 2023, selling an estimated $354K.
- McMillion Capital Management's ten largest holdings make up 41% of its $112M portfolio in Q2 2023.
- McMillion Capital Management opened 123 new positions and closed 1 in Q2 2023.
- McMillion Capital Management's portfolio value rose 5.9% quarter-over-quarter to $112M.
Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.